I’ll guess Kris. My only issue with this is that it’s insider info that should be revealed in a SEC filing. I wasn’t thrilled with Olaregen at first because salaries and bonuses were ridiculously high when I read their filings. Hopefully, at some point that acquisition reaps rewards.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links